Modifying epigenetics as a novel treatment in COPD [ 2015 - 2019 ]

Research Grant

Researchers: Prof Philip Hansbro (Principal investigator) ,  Prof Darryl Knight ,  Prof Ian Adcock ,  Prof Peter Wark

Brief description Smoking leads to inflammation that causes emphysema, which is a major health problem. Once induced there is a progressive decline in health, which continues even after stopping smoking. There are no treatments that halt this decline. Recently smoking-induced changes in genes have been discovered that control inflammation. We may be able to reverse these changes and stop the induction and progression of emphysema. This project may lead to a completely new way of preventing and treating emphysema.

Funding Amount $AUD 1,122,854.59

Funding Scheme Project Grants

Notes Standard Project Grant